Perbak Capital Partners LLP Invests $1.13 Million in Danaher Co. (NYSE:DHR)

Perbak Capital Partners LLP acquired a new position in Danaher Co. (NYSE:DHR) during the fourth quarter, Holdings Channel reports. The firm acquired 4,911 shares of the conglomerate’s stock, valued at approximately $1,127,000.

A number of other large investors have also added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher during the fourth quarter valued at $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher during the fourth quarter valued at $31,000. Strategic Financial Concepts LLC purchased a new position in Danaher in the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC boosted its position in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Trading Down 0.6 %

Shares of Danaher stock opened at $196.01 on Tuesday. The firm has a market capitalization of $140.28 billion, a PE ratio of 37.12, a P/E/G ratio of 2.66 and a beta of 0.86. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The firm’s 50-day moving average price is $200.69 and its 200 day moving average price is $223.46. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. On average, sell-side analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were paid a $0.32 dividend. The ex-dividend date of this dividend was Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher’s payout ratio is presently 24.85%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Robert W. Baird dropped their target price on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Wells Fargo & Company dropped their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. UBS Group lowered their price objective on shares of Danaher from $275.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Jefferies Financial Group lowered their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Finally, Barclays increased their price objective on shares of Danaher from $205.00 to $215.00 and gave the company an “overweight” rating in a research report on Tuesday, April 22nd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $264.40.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.